70 related articles for article (PubMed ID: 3172485)
21. [Application of the peripheral leukocyte cytofluorogram to diagnosis and treatment of hematopoietic tumors--with special reference to its effectiveness in malignant lymphoma].
Kamimura N; Fukuiya Y; Komatsu M; Itagaki M
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1285-92. PubMed ID: 6964048
[TBL] [Abstract][Full Text] [Related]
22. Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma.
Riben MW; Malfetano JH; Nazeer T; Muraca PJ; Ambros RA; Ross JS
Mod Pathol; 1997 Aug; 10(8):823-31. PubMed ID: 9267826
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis.
Vora HH; Shah NG; Patel DD; Trivedi TI; Chikhlikar PR
J Surg Oncol; 2003 Jan; 82(1):34-50. PubMed ID: 12501167
[TBL] [Abstract][Full Text] [Related]
24. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
[TBL] [Abstract][Full Text] [Related]
25. Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer: a multicenter portability study.
Persons DL; Bui MM; Lowery MC; Mark HF; Yung JF; Birkmeier JM; Wong EY; Yang SJ; Masood S
Ann Clin Lab Sci; 2000 Jan; 30(1):41-8. PubMed ID: 10678582
[TBL] [Abstract][Full Text] [Related]
26. [Detection of 8 oncogenes in squamous epithelial cancers of the head and neck].
Jungehülsing M; Volling P
HNO; 1994 May; 42(5):280-7. PubMed ID: 8050916
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometry in cancer diagnosis.
O'Hara MF; Bedrossian CW; Johnson TS; Barlogie B
Prog Clin Pathol; 1984; 9():135-53. PubMed ID: 6364220
[No Abstract] [Full Text] [Related]
28. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
Bremnes RM; Sirera R; Camps C
Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation.
Kazakov DV; Ivan D; Kutzner H; Spagnolo DV; Grossmann P; Vanecek T; Sima R; Kacerovska D; Shelekhova KV; Denisjuk N; Hillen U; Kuroda N; Mukensnabl P; Danis D; Michal M
Am J Dermatopathol; 2009 May; 31(3):236-47. PubMed ID: 19384064
[TBL] [Abstract][Full Text] [Related]
30. [Colorectal exfoliated cell in stool and its nuclear DNA quantitative analysis for diagnosis of colorectal cancer].
Fan RY; Li SR; Wu ZT; Wu X; Chen ZM
Ai Zheng; 2002 Jul; 21(7):776-80. PubMed ID: 12479106
[TBL] [Abstract][Full Text] [Related]
31. [Cytophotometric and automated cytodiagnosis].
Böcking A
Microsc Acta Suppl; 1983; 6():91-102. PubMed ID: 6578409
[TBL] [Abstract][Full Text] [Related]
32. [DNA cytometry of solitary and aneurysmal bone cysts and low malignancy and high malignancy central osteosarcomas. Current significance within the scope of morphologic diagnosis of intraosseous cystic and osteoblastic lesions].
Werner M; Heintz A; Delling G
Pathologe; 1996 Jan; 17(1):44-9. PubMed ID: 8685095
[TBL] [Abstract][Full Text] [Related]
33. [Detection of n-myc gene amplification in neuroblastoma using polymerase chain reaction based methods].
Melegh Z; Bálint I; Nagy K; Magyarosy E; Galántai I; Szentirmay Z
Magy Onkol; 2002; 46(1):43-8. PubMed ID: 12050681
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
Pechoux C; Chardonnet Y; Chignol MC; Noël P
Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
[TBL] [Abstract][Full Text] [Related]
35. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
Melegh Z; Bálint I; Tóth E; Csernák E; Szentirmay Z; Nagy K
Pediatr Pathol Mol Med; 2003; 22(3):213-22. PubMed ID: 12746172
[TBL] [Abstract][Full Text] [Related]
36. [DNA content analysis and detection of c-myc and p53 products using flow cytometry in resected lung cancer cases].
Chiba W; Sawai S; Ikeda S; Morimoto K; Wazawa H; Hanawa T; Yamashita N; Matsui T; Hatakenaka R; Matsubara Y
Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():108-16. PubMed ID: 8203922
[TBL] [Abstract][Full Text] [Related]
37. Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event.
Young KH; Xie Q; Zhou G; Eickhoff JC; Sanger WG; Aoun P; Chan WC
Am J Clin Pathol; 2008 Jan; 129(1):157-66. PubMed ID: 18089500
[TBL] [Abstract][Full Text] [Related]
38. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
39. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
40. Image analysis and flow cytometric DNA studies of benign and malignant body cavity fluids: reappraisal of the role of current methods in the differential diagnosis of reactive versus malignant conditions.
Lazcano O; Chen LM; Tsai C; Li CY; Katzmann JA; Sebo TJ; Kimlinger TK; Baker J
Mod Pathol; 2000 Jul; 13(7):788-96. PubMed ID: 10912939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
